While making efforts to attract investment, the healthcare sector yet to meet its expectations. Nguyen Thi Lien Huong, Deputy Minister of Health, talked with VIR’s Bich Thuy the next steps ahead to make improvements.
While the shift to the hospital channel brought fruitful results for major pharma players in Vietnam in 2023, competition is forecast to heat up in the future.
Japan’s century-old ASKA Pharmaceutical Co., Ltd plans to increase its stake in Ha Tay Pharmaceutical JSC, traded on the Hanoi Stock Exchange as DHT, to 33%.
Vietnam has become a top choice for Japanese investors due to its strong economic growth, large consumer base, competitive labour costs, and favourable rentals.